These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 2416128

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Individualization of gamma globulin dosage in patients with humoral immunodeficiency.
    Schiff RI, Rudd C, Johnson R, Buckley RH.
    Birth Defects Orig Artic Ser; 1983; 19(3):209-12. PubMed ID: 6197106
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Safety and patient acceptability of intravenous immune globulin in 10% maltose.
    Ochs HD, Buckley RH, Pirofsky B, Fischer SH, Rousell RH, Anderson CJ, Wedgwood RJ.
    Lancet; 1980 Nov 29; 2(8205):1158-9. PubMed ID: 6107768
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Role of intravenous immunoglobulin in prevention and treatment of neonatal infection.
    Irani SF, Wagle SU, Deshpande PG.
    Indian Pediatr; 1991 Apr 29; 28(4):443-9. PubMed ID: 1721607
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.
    Wahn V, Good RA, Gupta S, Pahwa S, Day NK.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Apr 29; 284():49-58. PubMed ID: 6203331
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical tolerance and catabolism of plasmin-treated gamma-globulin for intravenous application.
    Barandun S, Castel V, Makula MF, Morell A, Plan R, Skvaril F.
    Vox Sang; 1975 Apr 29; 28(3):157-75. PubMed ID: 47211
    [Abstract] [Full Text] [Related]

  • 32. The use of intravenous immune globulin in immunodeficiency diseases.
    Buckley RH, Schiff RI.
    N Engl J Med; 1991 Jul 11; 325(2):110-7. PubMed ID: 2052044
    [No Abstract] [Full Text] [Related]

  • 33. Anti-immunoglobulin antibodies in immunodeficiencies: their influence on intolerance reactions to gamma-globulin administration.
    Ropars C, Caldera LH, Griscelli C, Homberg JC, Salmon C.
    Vox Sang; 1974 Jul 11; 27(4):294-301. PubMed ID: 4137541
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
    Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP.
    N Engl J Med; 1991 Jun 06; 324(23):1633-9. PubMed ID: 1709446
    [Abstract] [Full Text] [Related]

  • 39. Thirty years of supplying the missing link. History of gamma globulin therapy for immunodeficient states.
    Dwyer JM.
    Am J Med; 1984 Mar 30; 76(3A):46-52. PubMed ID: 6201067
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.